news-details
Healthcare & Biotech,Metals & Mining,Consumer,Technology,Health,Electric Vehicles,Pot Stock,5G Stock,Energy,Dividend,Watchlist,Earnings,healthcare stocks

5 Day Gainers Report

 Powered by HealthTechMovers.com

We have identified 7 Five Day Gainers of all US Exchanges; they are receiving Bullish Sentiment from investors and financial bloggers.

In addition, they are generating positive media buzz and/or have insider trading signals which came to our attention.  This list below is subject to change on a daily basis, so please be sure you subscribe to our email newsletter.

If you have other stocks that you are researching, then you need to Join TipRanks.com Now to get insights on every stock being traded!


Avadel Pharmaceuticals, AVDL
Summary: Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.
  • Last Price: $4.63
  • Price Change: $0.38, 8.94%
  • Yearly Gain: -41.22%
  • Market Cap: $252.96M
  • P/E Ratio: -2.765

Here are 3rd party ratings for AVDL:

  • TipRanks.com: Strong Buy
  • TradingView.com: n/a
  • Yahoo! Finance: Bullish Short-Term Outlook
  • Barchart.com: sell
  • Zacks.com: Hold, Top 36% (89 out of 251)

What is the sentiment on the street regarding Avadel Pharmaceuticals (Current ratings compiled by TipRanks.com)

  • News Sentiment: Very Bullish
  • Blogger Consensus: Bullish
  • Media Buzz: Low
  • Insider Signal: Positive
  • Investor Sentiment: Positive
  • Hedge Fund signal: Positive

If you are interested in AVDL or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on AVDL before you decide to make any investment.

Click here for chart >>

---------------------------------------------------------------------------

Microstrategy, MSTR
Summary: MicroStrategy Incorporated, a leading worldwide provider of business intelligence software, today announced that GT Nexus has selected MicroStrategy to power the customer-facing analytics and reporting capabilities on its Global Logistics portal. The GT Nexus portal is an on demand technology platform that is used by importers, exporters, transportation carriers, suppliers, banks, and other partners to manage goods that are moving around the world. The GT Nexus system captures and stores hard-to-get data associated with global supply chains, and then fuels a range of Web applications that can be used by constituents to lower supply chain costs and improve control. MicroStrategy will help GT Nexus to deliver a wide range of analytics and reporting capabilities to its customers, which include Home Depot, Kmart, Xerox, Weyerhaeuser, and American Eagle Outfitters.
  • Last Price: $229.25
  • Price Change: $9.74, 4.44%
  • Yearly Gain: -64.50%
  • Market Cap: $2.48B
  • P/E Ratio: -4.039

Here are 3rd party ratings for MSTR:

  • TipRanks.com: Strong Buy
  • TradingView.com: Neutral
  • Yahoo! Finance: Bullish Short-Term Outlook
  • Barchart.com: sell
  • Zacks.com: Strong Sell, Bottom 40% (150 out of 251)

What is the sentiment on the street regarding Microstrategy (Current ratings compiled by TipRanks.com)

  • News Sentiment: Neutral
  • Blogger Consensus: Neutral
  • Media Buzz: Very Low
  • Insider Signal: Positive
  • Investor Sentiment: Positive
  • Hedge Fund signal: Negative

If you are interested in MSTR or any stocks within the Technology sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on MSTR before you decide to make any investment.

Click here for chart >>

---------------------------------------------------------------------------

Verrica Pharmaceuticals, VRCA
Summary: Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company. It develops and manufactures pharmaceutical products for the treatment of skin diseases such as molluscum contagiosum and dermatology. Verrica Pharmaceuticals, Inc. is based in PA, United States.
  • Last Price: $3.19
  • Price Change: $0.17, 5.63%
  • Yearly Gain: -71.96%
  • Market Cap: $119.35M
  • P/E Ratio: -1.95

Here are 3rd party ratings for VRCA:

  • TipRanks.com: Moderate Buy
  • TradingView.com: Neutral
  • Yahoo! Finance: Bullish Short-Term Outlook
  • Barchart.com: Strong sell
  • Zacks.com: Buy, Top 36% (89 out of 251)

What is the sentiment on the street regarding Verrica Pharmaceuticals (Current ratings compiled by TipRanks.com)

  • News Sentiment: Neutral
  • Blogger Consensus:
  • Media Buzz: Medium
  • Insider Signal: Positive
  • Investor Sentiment: Neutral
  • Hedge Fund signal: Neutral

If you are interested in VRCA or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on VRCA before you decide to make any investment.

Click here for chart >>

---------------------------------------------------------------------------

Oramed Pharmaceuticals, ORMP
Summary: Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel.
  • Last Price: $7.24
  • Price Change: $1.56, 27.46%
  • Yearly Gain: -53.63%
  • Market Cap: $219.04M
  • P/E Ratio: -6.899

Here are 3rd party ratings for ORMP:

  • TipRanks.com: Moderate Buy
  • TradingView.com: Buy
  • Yahoo! Finance: Bullish Short-Term Outlook
  • Barchart.com: sell
  • Zacks.com: n/a, n/a

What is the sentiment on the street regarding Oramed Pharmaceuticals (Current ratings compiled by TipRanks.com)

  • News Sentiment: Neutral
  • Blogger Consensus: Bullish
  • Media Buzz: Very Low
  • Insider Signal: Negative
  • Investor Sentiment: Neutral
  • Hedge Fund signal: No Signal

If you are interested in ORMP or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on ORMP before you decide to make any investment.

Click here for chart >>

---------------------------------------------------------------------------

Cardiff Oncology, CRDF
Summary: Cardiff Oncology Inc. is a clinical-stage biotechnology company. It engages in developing treatment for cancer patients. The company's product pipeline consists of a Phase 1b/2 study of onvansertib in combination with FOLFIRI/Avastin(R) in KRAS-mutated metastatic colorectal cancer; a Phase 2 study of onvansertib in combination with Zytiga(R) in Zytiga-resistant metastatic castration-resistant prostate cancer; and a Phase 2 study of onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia. Cardiff Oncology Inc., formerly known as Trovagene Inc., is based in SAN DIEGO.
  • Last Price: $3.23
  • Price Change: $0.11, 3.53%
  • Yearly Gain: -52.22%
  • Market Cap: $135.11M
  • P/E Ratio: -3.729

Here are 3rd party ratings for CRDF:

  • TipRanks.com: Strong Buy
  • TradingView.com: Buy
  • Yahoo! Finance: Bullish Short-Term Outlook
  • Barchart.com: Weak buy
  • Zacks.com: Hold, Top 31% (78 out of 251)

What is the sentiment on the street regarding Cardiff Oncology (Current ratings compiled by TipRanks.com)

  • News Sentiment: Neutral
  • Blogger Consensus: Bullish
  • Media Buzz: Very Low
  • Insider Signal: Positive
  • Investor Sentiment: Neutral
  • Hedge Fund signal: Neutral

If you are interested in CRDF or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on CRDF before you decide to make any investment.

Click here for chart >>

---------------------------------------------------------------------------

Oak Street Health, OSH
Summary: Oak Street Health Inc. is a primary care centers for adults on Medicare. It operates principally in Illinois, Michigan, Indiana, Pennsylvania, Ohio, Rhode Island, North Carolina, Tennessee and Texas. Oak Street Health Inc. is based in Chicago, United States.
  • Last Price: $23.7
  • Price Change: -$0.21, -0.88%
  • Yearly Gain: -62.85%
  • Market Cap: $5.76B
  • P/E Ratio: -12.09

Here are 3rd party ratings for OSH:

  • TipRanks.com: Moderate Buy
  • TradingView.com: n/a
  • Yahoo! Finance: Bullish Short-Term Outlook
  • Barchart.com: Weak sell
  • Zacks.com: Hold, Bottom 33% (168 out of 251)

What is the sentiment on the street regarding Oak Street Health (Current ratings compiled by TipRanks.com)

  • News Sentiment: Neutral
  • Blogger Consensus:
  • Media Buzz: Medium
  • Insider Signal:
  • Investor Sentiment: Negative
  • Hedge Fund signal: Very Positive

If you are interested in OSH or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on OSH before you decide to make any investment.

Click here for chart >>

---------------------------------------------------------------------------

CS Disco, LAW
Summary: CS Disco Inc. provides software service solutions. The Company offers cloud based, artificial intelligence-powered legal solution which simplifies ediscovery, legal document review and case management for enterprises, law firms, legal services providers and governments. CS Disco Inc. is based in AUSTIN, Texas.
  • Last Price: $24.86
  • Price Change: $0.82, 3.41%
  • Yearly Gain: -41.37%
  • Market Cap: $1.41B
  • P/E Ratio: -41.743

Here are 3rd party ratings for LAW:

  • TipRanks.com: Strong Buy
  • TradingView.com: Buy
  • Yahoo! Finance: Bullish Short-Term Outlook
  • Barchart.com: sell
  • Zacks.com: Hold, Bottom 44% (139 out of 251)

What is the sentiment on the street regarding CS Disco (Current ratings compiled by TipRanks.com)

  • News Sentiment:
  • Blogger Consensus: Bullish
  • Media Buzz:
  • Insider Signal: Positive
  • Investor Sentiment: Very Negative
  • Hedge Fund signal: Neutral

If you are interested in LAW or any stocks within the Technology sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on LAW before you decide to make any investment.

Click here for chart >>

---------------------------------------------------------------------------


Thanks for reading!